18-2750446-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_015295.3(SMCHD1):​c.4104C>T​(p.Pro1368Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00162 in 1,611,098 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0024 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 22 hom. )

Consequence

SMCHD1
NM_015295.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.29

Publications

3 publications found
Variant links:
Genes affected
SMCHD1 (HGNC:29090): (structural maintenance of chromosomes flexible hinge domain containing 1) This gene encodes a protein which contains a hinge region domain found in members of the SMC (structural maintenance of chromosomes) protein family. [provided by RefSeq, Dec 2011]
SMCHD1 Gene-Disease associations (from GenCC):
  • arhinia, choanal atresia, and microphthalmia
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics, ClinGen, Illumina
  • facioscapulohumeral muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 18-2750446-C-T is Benign according to our data. Variant chr18-2750446-C-T is described in ClinVar as Benign. ClinVar VariationId is 260647.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.29 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00237 (360/152084) while in subpopulation EAS AF = 0.033 (171/5186). AF 95% confidence interval is 0.0289. There are 5 homozygotes in GnomAd4. There are 165 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 360 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMCHD1NM_015295.3 linkc.4104C>T p.Pro1368Pro synonymous_variant Exon 32 of 48 ENST00000320876.11 NP_056110.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMCHD1ENST00000320876.11 linkc.4104C>T p.Pro1368Pro synonymous_variant Exon 32 of 48 5 NM_015295.3 ENSP00000326603.7 A6NHR9-1

Frequencies

GnomAD3 genomes
AF:
0.00236
AC:
359
AN:
151966
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00111
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00695
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0329
Gnomad SAS
AF:
0.00415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000883
Gnomad OTH
AF:
0.00481
GnomAD2 exomes
AF:
0.00474
AC:
1160
AN:
244746
AF XY:
0.00373
show subpopulations
Gnomad AFR exome
AF:
0.00147
Gnomad AMR exome
AF:
0.0154
Gnomad ASJ exome
AF:
0.000405
Gnomad EAS exome
AF:
0.0306
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000722
Gnomad OTH exome
AF:
0.00302
GnomAD4 exome
AF:
0.00154
AC:
2243
AN:
1459014
Hom.:
22
Cov.:
31
AF XY:
0.00142
AC XY:
1031
AN XY:
725652
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33428
American (AMR)
AF:
0.0147
AC:
650
AN:
44292
Ashkenazi Jewish (ASJ)
AF:
0.000154
AC:
4
AN:
26000
East Asian (EAS)
AF:
0.0288
AC:
1139
AN:
39580
South Asian (SAS)
AF:
0.00179
AC:
154
AN:
85928
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53304
Middle Eastern (MID)
AF:
0.000696
AC:
4
AN:
5750
European-Non Finnish (NFE)
AF:
0.0000711
AC:
79
AN:
1110458
Other (OTH)
AF:
0.00320
AC:
193
AN:
60274
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.429
Heterozygous variant carriers
0
102
205
307
410
512
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00237
AC:
360
AN:
152084
Hom.:
5
Cov.:
32
AF XY:
0.00222
AC XY:
165
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.00111
AC:
46
AN:
41502
American (AMR)
AF:
0.00701
AC:
107
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.0330
AC:
171
AN:
5186
South Asian (SAS)
AF:
0.00394
AC:
19
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000883
AC:
6
AN:
67958
Other (OTH)
AF:
0.00523
AC:
11
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00143
Hom.:
0
Bravo
AF:
0.00287
Asia WGS
AF:
0.0250
AC:
85
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jun 02, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 07, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Facioscapulohumeral muscular dystrophy 2 Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
3.5
DANN
Benign
0.76
PhyloP100
-1.3
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117794949; hg19: chr18-2750444; COSMIC: COSV55269269; COSMIC: COSV55269269; API